David Esrig

5.7k citations
53 papers · 4.7k · 3 hit papers · h-index 27

Impact in

  • Surgery top 0.5%
    • Bladder and Urothelial Cancer Treatments
    • Urinary and Genital Oncology Studies
  • Urology top 1%
    • Urinary Bladder and Prostate Research
    • Urological Disorders and Treatments

Papers in

    • Bladder and Urothelial Cancer Treatments 38
    • Urological Disorders and Treatments 6
    • Urinary Bladder and Prostate Research 5

David Esrig

53 papers receiving 4.4k citations

David Esrig's Hit Papers

Two molecular pathways to transitional cell carcinoma of the bladder. 1994 · 515 citations
5150+11+22Years since publication200400600

Peers

David Esrig
Comparison fields: 5 of 81
  • Surgery 3.5k
  • Urology 255
  • Pulmonary and Respiratory Medicine 495
  • Oncology 356
  • Cancer Research 154
Replace Semra Olgac with:
Semra Olgac United States
M.P.W. Gallee Netherlands
Tohru Nakagawa Japan
Heiko Wunderlich Germany
P. L. Esposti Sweden
James L. Bennington United States
Sangeeta B. Desai India
Toru Harabayashi Japan
Carsten Kempkensteffen Germany
Yoshiaki Imamura Japan
David Esrig relative to Semra Olgac United States Semra Olgac's profile →
Citations per field
00.5×2×4×5.8×
Semra Olgac · 1×
Citations per year

Countries citing papers authored by David Esrig

Since Specialization
Citations

This map shows the geographic impact of David Esrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Esrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Esrig more than expected).

Fields of papers citing papers by David Esrig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Esrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Esrig. The network helps show where David Esrig may publish in the future.

Co-authors

The 25 scholars most cited alongside David Esrig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Esrig Line = papers co-authored together David Esrig links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer
Hit paper breakdown →
1994652
2
Two molecular pathways to transitional cell carcinoma of the bladder.
Hit paper breakdown →
1994515
3
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
Hit paper breakdown →
1993419
4 1997268
5 1998257
6 1998237
7 1997229
8 2011185
9 1996156
10 1995144
11 1996139
12 1995138
13 1996121
14 1997116
15 1995115
16 1994107
17 1994103
18 199793
19 199883
20 199476

About David Esrig

David Esrig is a scholar working on Surgery, Urology, Pulmonary and Respiratory Medicine, Oncology and Obstetrics and Gynecology, having authored 53 papers that have together received 4.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (38 papers), Urological Disorders and Treatments (6 papers), Urinary Bladder and Prostate Research (5 papers), Cancer-related Molecular Pathways (4 papers), Renal cell carcinoma treatment (4 papers), Prostate Cancer Treatment and Research (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Aortic aneurysm repair treatments (2 papers). The work is most often cited by research in Surgery (3.5k citations), Urology (255 citations), Pulmonary and Respiratory Medicine (495 citations), Oncology (356 citations) and Cancer Research (154 citations). David Esrig has collaborated with scholars based in United States, Austria and Denmark. Frequent co-authors include Donald G. Skinner, John P. Stein, Richard J. Côté, Susan G. Groshen, Peter A. Jones, Peter W. Nichols, Donald A. Elmajian, Gary Lieskovsky, John A. Freeman and Gary D. Grossfeld. Their work appears in journals such as The Journal of Urology, Urology, World Journal of Urology, JNCI Journal of the National Cancer Institute and Urologic Clinics of North America.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact